首页|期刊导航|iLABMED|Integrating Biomarker-Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors

Integrating Biomarker-Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors

Xudong Song Jingjing Dai Guoquan Tao

iLABMED2026，Vol.4Issue(2)：P.130-131,2.

iLABMED2026，Vol.4Issue(2)：P.130-131,2.DOI:10.1002/ila2.70056

Integrating Biomarker-Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors

Xudong Song ¹Jingjing Dai ²Guoquan Tao¹

作者信息

1. Department of Gastrointestinal Surgery,The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University,Huai’an,China
2. Department of Medical Laboratory,The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University,Huai’an,China
折叠

摘要

关键词

digestive tumor/fatty liver index/metabolic-associated fatty liver disease/multidisciplinary treatment/perioperative management

分类

医药卫生

引用本文复制引用

Xudong Song,Jingjing Dai,Guoquan Tao..Integrating Biomarker-Based Fatty Liver Indices Into Multidisciplinary Treatment Pathways for Digestive Tumors[J].iLABMED,2026,4(2):P.130-131,2.

基金项目

supported by the National Natural Science Foundation of China(Grant 81773538) （Grant 81773538）

the Special Fund for the Construction of Key Medical Discipline Laboratories in Jiangsu Province(Grant JSDW202233) （Grant JSDW202233）

the Jiangsu Province’s Sixth“333 Project”Talent Support Special Fund(Grant S333YQ002). （Grant S333YQ002）

iLABMED

ISSN：2834-443X

访问量0

下载量0

段落导航